TNF and breast carcinoma: Conversely, human breast cancer cells treated with 1,25(OH)2D showed decreased proliferation, in part induced by the reduced TNF-α and IL-1β synthesis, by demonstrating that even drastic deregulation of immune modulators may contribute to cancer progression [137].